Table 1.
Gene family | Gene name | Locus | Function/role | Effect on tissue tropism | Potential effect on disease severity |
---|---|---|---|---|---|
Omp family | omp A | ct681 | Most prominent outer membrane protein; porin; antigen-variants |
Classification of Chlamydia trachomatis serovars into A–K and LGV |
No correlation between ompA and disease severity demonstrated |
| |||||
Pmp family | pmp A | ct412 | Type V secreted proteins: some members (D, E, G and H) are expressed on the EB surface. PmpD, D and G elicit a strong inflammatory response. All of these proteins likely play a role in phase variation |
Unknown | High variability of pmp genes by SNPs, gene duplication and indel mutations may be significant in contributing to disease severity |
pmpB | ct413 | Specific amino acid substitutions distinguish LGV from non-LGV; difference in C. trachomatis E and F to other genital serovars |
|||
pmpC | ct414 | Specific amino acid substitutions distinguish LGV from non-LGV; difference in C. trachomatis E and F to other genital serovars |
|||
pmpD | ct812 | Specific amino acid substitutions distinguish LGV from non-LGV |
|||
pmpE | ct869 | Specific nucleotide substitutions segregate ocular from urogenital and LGV; difference in C. trachomatis E and F to other genital serovars |
|||
pmpF | ct870 | Specific nucleotide substitutions segregate ocular from urogenital and LGV |
|||
pmpG | ct871 | Specific amino acid substitutions distinguish LGV from non-LGV |
|||
pmpH | ct872 | Specific nucleotide substitutions segregate ocular from urogenital and LGV; difference in C. trachomatis E and F to other genital serovars |
|||
pmpl | ct874 | Difference in C. trachomatis E and F to other genital serovars | |||
tarp | ct456 | Binds to actin, phosphorylated by host kinases; cytoskeleton rearrangement; involved in internalization |
Number of actin-binding sites differentiate LGV and non-LGV; number of actin-binding sites important for tropism? |
Number of actin-binding sites important for disease severity? |
|
| |||||
Inc proteins | incD | ctll 5 | Sphingolipid transport; interacts with CERT |
Mutations in incD specific to ocular and LGV tissue tropism | Unknown |
incE | ct116 | Unknown | Unknown | Unknown | |
incF | ct117 | Unknown | Unknown | Unknown | |
incG | ctll8 | Blocks release of cytochrome C and inhibits apoptosis |
Unknown | Unknown | |
incA | ct119 | Homotypic fusion of intracellular inclusions |
In LGV the genetic variation of incA may reflect tissue tropism |
Nonfusogenic clinical isolates have less severe clinical signs |
|
ct229f † | Modulation of inclusion trafficking; binds to Rab4A |
Unknown | Unknown | ||
incB | ct232 | Unknown | Unknown | Unknown | |
incC | ct233 | Unknown | Unknown | Unknown | |
aaxB | ct373 | AAX: arginine decarboxylase proenzyme; inhibits host cell polyamine synthesis, or inhibition of nitric oxide synthesis? |
Unknown | Unknown | |
aaxC | ct374 | AAX: cytoplasmic arginine:agmatine antiporter; inhibits host cell polyamine synthesis, or inhibition of nitric oxide synthesis? |
Unknown | Unknown | |
trpA | ct171 | Subunit of Trp synthase, which produces Trp from indole |
Mutations in trpA segregate ocular from genital isolates | Unknown | |
ct166f | Toxin-like protein; glycosylates Rac1; causing actin reorganization |
Contains serovar specific loci, missing in LGV strains; potential role in invasiveness? |
Potentially plays a role in disease severity (LGV strains lack the cytotoxin) |
These loci have not, as yet, been named.
AAX: Arginine:agmatine exchange system; EB: Elementary body; Indel: Insertion and deletion; LGV: Lymphogranuloma venereum; SNP: Single nucleotide polymorphism.